Currently Used and New Molecular Markers for Thyroid Cancer Diagnosis
Publish place: Middle East Journal of Cancer، Vol: 13، Issue: 2
Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 39
This Paper With 23 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_MISJ-13-2_001
تاریخ نمایه سازی: 25 آبان 1402
Abstract:
Thyroid cancer is highly common all around the world. Its prevalence has rapidly increased over the last ۳۰ years in the United States and other developing countries. Fine-needle aspiration biopsy has become the cornerstone of thyroid nodule diagnosis, whose general reliability is outstanding; however, some aspirates have shown undetermined cytological findings that do not provide a definitive malignancy diagnosis. At least ۷۰ molecular and genetic markers in thyroid nodules have been analyzed in an effort to identify molecular markers to differentiate malignant and benign (BN) thyroid nodules. The present review focused on the currently used markers in thyroid cancer diagnosis. A rising number of studies have investigated immunohistochemical markers, such as galectin-۳ (GAL۳), cytokeratin ۱۹ (CK۱۹), hector battifora mesothelial- ۱ (HBME-۱), and thyroid peroxidase, along with DNA alterations, including mainly BRAF (B-Raf proto-oncogene, serine/threonine kinase) and RAS (Ras proto-oncogene, GTPase) point mutations, Telomerase reverse transcriptase mutations, ret protooncogene/ papillary thyroid carcinoma and PAX۸/PPARG rearrangements, and miRNA signatures and circulating tumor cells for thyroid cancer diagnosis. Although certain markers are promising for differential diagnosis, due to limitations of the substantial prevalence of BN thyroid tumors, none of them is specifically definitive to a large extent. Herein, we also discussed the studies that have supported the use of combinations of several markers, like KIT, TC۱, miR-۲۲۲, and miR-۱۴۶b combination, as well as GAL۳, CK۱۹, and HBME-۱ combination, in enhancing the diagnostic accuracy in differentiating malignant and BN tumors.
Keywords:
Authors
Hatem Hejaz
College of Pharmacy and Medical Sciences, Hebron University, Hebron, Palestine
Isra&#۰۳۹; Abuzaina
College of Pharmacy and Medical Sciences, Hebron University, Hebron, Palestine
Reem Aldeen
College of Pharmacy and Medical Sciences, Hebron University, Hebron, Palestine
Sondos Saad
College of Pharmacy and Medical Sciences, Hebron University, Hebron, Palestine
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :